Search Results - Mathias B. Møllerhøj

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosis

    Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosis by Hansen, Henrik H., Pors, Susanne, Andersen, Maja W., Vyberg, Mogens, Nøhr-Meldgaard, Jacob, Nielsen, Malte Hasle, Oró, Denise, Madsen, Martin Rønn, Lewinska, Monika, Møllerhøj, Mathias B., Madsen, Andreas Nygaard, Feigh, Michael

    Published in Scientific reports
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity

    A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity by Hagemann, Christoffer A, Legart, Christian, Møllerhøj, Mathias B, Madsen, Martin R, Hansen, Henrik H, Kønig, Merete J, Helgstrand, Frederik, Hjørne, Flemming P, Toxværd, Anders, Langhoff, Jill L, Kielgast, Urd L, Gluud, Lise L, Ægidius, Helene, Rigbolt, Kristoffer T. G, Vilsbøll, Tina, Jelsing, Jacob, Knop, Filip K

    Published in PloS one
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet‐induced obese and biopsy‐confirmed mouse model of NASH

    Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet‐induced obese and biopsy‐confirmed mouse model of NASH by Møllerhøj, Mathias B., Veidal, Sanne S., Thrane, Kirstine Tølbøl, Oró, Denise, Overgaard, Agnete, Salinas, Casper Gravesen, Madsen, Martin Rønn, Pfisterer, Larissa, Vyberg, Mogens, Simon, Eric, Broermann, Andre, Vrang, Niels, Jelsing, Jacob, Feigh, Michael, Hansen, Henrik H.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity

    A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity by Christoffer A. Hagemann, Christian Legart, Mathias B. Møllerhøj, Martin R. Madsen, Henrik H. Hansen, Merete J. Kønig, Frederik Helgstrand, Flemming P. Hjørne, Anders Toxværd, Jill L. Langhoff, Urd L. Kielgast, Lise L. Gluud, Helene Ægidius, Kristoffer T. G. Rigbolt, Tina Vilsbøll, Jacob Jelsing, Filip K. Knop

    Published in PloS one
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    SAT-218 - Differential hepatoprotective effects of semaglutide and lanifibranor in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH with advanced fibrosis and HCC

    SAT-218 - Differential hepatoprotective effects of semaglutide and lanifibranor in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH with advanced fibrosis and HC... by Nielsen, Malte H., Pors, Susanne, Nøhr-Meldgaard, Jacob, Madsen, Andreas Nygaard, Møllerhøj, Mathias Bonde, Oró, Denise, Vyberg, Mogens, Hansen, Henrik B., Feigh, Michael

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    TOP-036 - Liver cell-type specific molecular signatures marking transition from advanced fibrosis to cirrhosis in human non-alcoholic steatohepatitis

    TOP-036 - Liver cell-type specific molecular signatures marking transition from advanced fibrosis to cirrhosis in human non-alcoholic steatohepatitis by Madsen, Martin Rønn, Møllerhøj, Mathias, Werge, Mikkel, Christensen-Dalsgaard, Mikkel, Veidal, Sanne, Rudkjær, Lise, Galsgaard, Elisabeth, Gluud, Lise Lotte, Hansen, Henrik B.

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Liver cell-type specific molecular signatures marking transition from advanced fibrosis to cirrhosis in human non-alcoholic steatohepatitis

    Liver cell-type specific molecular signatures marking transition from advanced fibrosis to cirrhosis in human non-alcoholic steatohepatitis by Madsen, Martin Rønn, Møllerhøj, Mathias, Werge, Mikkel, Christensen-Dalsgaard, Mikkel, Veidal, Sanne, Rudkjær, Lise, Galsgaard, Elisabeth, Gluud, Lise Lotte, Hansen, Henrik B.

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Differential hepatoprotective effects of semaglutide and lanifibranor in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH with advanced fibrosis and HCC

    Differential hepatoprotective effects of semaglutide and lanifibranor in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH with advanced fibrosis and HCC by Nielsen, Malte H., Pors, Susanne, Nøhr-Meldgaard, Jacob, Madsen, Andreas Nygaard, Møllerhøj, Mathias Bonde, Oró, Denise, Vyberg, Mogens, Hansen, Henrik B., Feigh, Michael

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: